Abstract

TPS4590 Background: High grade non-muscle invasive bladder cancer (NMIBC) has a 70% recurrence rate and rate of 15-30% progression. The standard of care is an induction course of bacillus Calmette-...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Commentary on “The value of transurethral bladder biopsy after intravesical bacillus Calmette-Guérin instillation therapy for nonmuscle invasive bladder cancer: a retrospective, single center study and cumulative analysis of the literature.” Swietek N, Waldert M, Rom M, Schatzl G, Wiener HG, Susani M, Klatte T. Department of Urology, Medical University of Vienna, Vienna, Austria: J Urol 2012;188(3):748-53 [Epub 2012 Jul 20
Ashish M Kamat
Seminars in urologic oncology | VOL. 31
Ashish M KamatAshish M Kamat
22 Jun 2013
Preoperative Neutrophils to Lymphocytes Ratio in Predicting the Response to BCG in High Grade Non-Muscle Invasive Bladder Cancer
Hany Mostafa Abdallah ... Ahmed Ibrahim Radwan
The Quarterly journal of medicine | VOL. 116
Hany Mostafa Abdallah, et. al.Hany Mostafa Abdallah ... Ahmed Ibrahim Radwan
23 Aug 2023
Abstract CT047: Phase I trial of intravesical Bacillus Calmette-Guérin combined with intravenous Pembrolizumab in high grade nonmuscle invasive bladder cancer
Shaheen Alanee ... Sherjeel Sana
American Journal of Cancer | VOL. 79
Shaheen Alanee, et. al.Shaheen Alanee ... Sherjeel Sana
01 Jul 2019
Abstract 436: ΔNp63 is critical for progression of high grade non-muscle invasive bladder cancer to muscle-invasive disease
Mireia Castillo-Martin ... Josep Maria Gaya-Sopena
American Journal of Cancer | VOL. 74
Mireia Castillo-Martin, et. al.Mireia Castillo-Martin ... Josep Maria Gaya-Sopena
30 Sep 2014
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial.
Alexios Matikas ...
Journal of Clinical Oncology | VOL. -
Alexios Matikas, et. al.Alexios Matikas ...
17 Jul 2024
Lymphoma Classifications, How to Develop a Future Unified Taxonomy.
Elias Campo ... Reiner Siebert
Journal of Clinical Oncology | VOL. -
Elias Campo, et. al.Elias Campo ... Reiner Siebert
17 Jul 2024
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors.
Brian C Shaffer ... Monzr M Al Malki
Journal of Clinical Oncology | VOL. -
Brian C Shaffer, et. al.Brian C Shaffer ... Monzr M Al Malki
17 Jul 2024
Genetic Counseling, Testing, and Family Communication Into Survivorship After Diagnosis of Breast Cancer.
Steven J Katz ... Allison W Kurian
Journal of Clinical Oncology | VOL. -
Steven J Katz, et. al.Steven J Katz ... Allison W Kurian
15 Jul 2024
View more papers